Arcutis Biotherapeutics, Inc. Common Stock ARQT
$26.19
+1.39%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $35.57
- Implied Upside
- +35.8%
- Price Target Range
- $29.00 – $40.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-06 | Morgan StanleyVikram Purohit |
Maintains | Overweight | $34 → $38 |
| 2026-08-06 | GuggenheimSeamus Fernandez |
Maintains | Buy | $35 → $38 |
| 2026-08-06 | NeedhamSerge Belanger |
Maintains | Buy | $36 → $40 |
| 2026-05-07 | NeedhamSerge Belanger |
Reiterates | Buy | $36 |
| 2026-03-02 | MizuhoUy Ear |
Maintains | Outperform | $37 → $35 |
| 2026-02-27 | GuggenheimSeamus Fernandez |
Maintains | Buy | $34 → $35 |
| 2026-02-26 | TD CowenTyler Van Buren |
Maintains | Buy | $30 → $35 |
| 2026-02-26 | HC Wainwright & Co.Douglas Tsao |
Maintains | Buy | $30 → $34 |
| 2026-02-26 | NeedhamSerge Belanger |
Maintains | Buy | $31 → $36 |
| 2026-01-26 | NeedhamSerge Belanger |
Maintains | Buy | $30 → $31 |
| 2025-11-28 | MizuhoUy Ear |
Maintains | Outperform | $32 → $37 |
| 2025-10-30 | Goldman Sachs Richard Law |
Maintains | Neutral | $19 → $29 |
| 2025-10-28 | NeedhamSerge Belanger |
Maintains | Buy | $22 → $30 |
| 2025-08-07 | NeedhamSerge Belanger |
Maintains | Buy | $20 → $22 |
| 2025-07-25 | Goldman Sachs Richard Law |
Initiates coverage on | Neutral | $18 |
| 2025-05-23 | NeedhamSerge Belanger |
Reiterates | Buy | $20 |
| 2025-04-09 | NeedhamSerge Belanger |
Reiterates | Buy | $20 |
| 2025-04-03 | GuggenheimSeamus Fernandez |
Reiterates | Buy | — |
| 2025-04-03 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $19 |
| 2025-04-03 | NeedhamSerge Belanger |
Reiterates | Buy | $20 |
| 2025-03-11 | JefferiesKambiz Yazdi |
Maintains | Buy | $16 → $19 |
| 2025-02-27 | Goldman SachsJonathan Block |
Maintains | Neutral | $13 → $15 |
| 2025-02-26 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $19 |
| 2025-02-26 | MizuhoUy Ear |
Maintains | Outperform | $20 → $21 |
| 2025-02-26 | NeedhamSerge Belanger |
Reiterates | Buy | $20 |
| 2025-02-24 | GuggenheimSeamus Fernandez |
Reiterates | Buy | — |
| 2025-02-10 | GuggenheimSeamus Fernandez |
Reiterates | Buy | — |
| 2025-01-13 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $19 |
| 2025-01-07 | MizuhoUy Ear |
Maintains | Outperform | $19 → $20 |
| 2024-12-30 | HC Wainwright & Co.Douglas Tsao |
Initiates coverage on | Buy | $19 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $26.19
- Market Cap
- $3.29 billion
- 52-Week Range
- $13.70 – $31.77
- Average Volume
- 1.52 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.